Two companies, Pfizer Inc. and Merck & Co Inc, are developing antiviral pills to treat COVID-19. Jamie Mauracher explains how each drug works, what they’ll cost, and where one has already been approved for use.
- FDA panel backs Merck’s COVID-19 pill, company touts effectiveness against variants
- Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says
- Pfizer sues employee for allegedly stealing confidential COVID-19 vaccine documents